Intercept Pharmaceuticals' (NASDAQ:ICPT) stunning 280% gain on Thursday left shareholders smiling. Some may have expected shares to pull back today, as investors tend to lock in profits after such big gains, but the stock popped more than 60% today. In the following video, analysts David Williamson and Max Macaluso discuss this stock's stellar performance and why investors are pushing shares higher.

Top stock pick for 2014
Intercept shareholders are smiling this week, but small biotechs can be risky for the average investor. Is there a stock poised to profit over the long term that can help you win over the long term? The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report: "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

David Williamson has no position in any stocks mentioned. Max Macaluso, Ph.D. has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Compare Brokers